Shares of NanoVibronix, Inc. (NASDAQ:NAOV – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.59 and traded as low as $0.49. NanoVibronix shares last traded at $0.52, with a volume of 66,581 shares traded.
NanoVibronix Stock Performance
The firm has a market cap of $1.43 million, a P/E ratio of -0.40 and a beta of 1.50. The business’s 50-day simple moving average is $0.59 and its 200 day simple moving average is $0.68.
NanoVibronix (NASDAQ:NAOV – Get Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.25) EPS for the quarter. The firm had revenue of $0.82 million for the quarter. NanoVibronix had a negative net margin of 83.49% and a negative return on equity of 74.98%.
About NanoVibronix
NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.
Further Reading
- Five stocks we like better than NanoVibronix
- What Are Some of the Best Large-Cap Stocks to Buy?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is MarketRank™? How to Use it
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.
